From GlobeNewswire: 2024-06-13 17:36:19

ONWARD Medical N.V. held its Annual General Meeting of Shareholders, where all proposed resolutions were passed. The company is focused on developing spinal cord stimulation therapies to restore movement, function, and independence in individuals with spinal cord injuries. The Company’s ARC Therapy™ has received multiple Breakthrough Device Designations from the FDA, showing promising results in clinical trials. ONWARD Medical continues to innovate and develop solutions to address movement disabilities and improve quality of life for those with spinal cord injuries and other conditions. For more information about the Company and its therapies, visit ONWD.com.



Read more at GlobeNewswire: ONWARD® Medical Announces Results of Annual General Meeting